Proxima
Renamed from VantAI.
Data as of .
Company facts
-
Founded
2019
-
Headquarters
United States (New York, NY)
Latest funding round
- Round
- Seed
- Date
- Jan 13, 2026
- Amount
- $80M
- Lead investor
- DCVC
Drug discovery partners
3 pharma, 1 other. Pharma here means a company with approved products and roughly $1B or more in annual revenue.
-
Johnson & Johnson Pharma
Signed contracts,
-
Bristol Myers Squibb Pharma
Signed contracts,
-
Sanofi (Blueprint) Pharma
Signed contracts,
-
Halda Therapeutics Biotech
Research collaboration,
$1B total potential (upfront not disclosed)
Big tech ties
Not counted as pharma partners.
-
NVIDIA (NVentures)
Investor ($80M round),
Recent news
-
Raised $80M led by DCVC with NVIDIA, Roivant and others
-
VantAI and Halda Therapeutics form an alliance on RIPTAC medicines
Confirmed means the company, a partner or a filing said it. Reported means a third party said it. This section sits outside the Pharma AI Tracker.
Spot an error? Tell me and I'll fix it.